Our Mission
R Validation Hub is a collaboration to support the adoption of R within a biopharmaceutical regulatory setting
The R Validation Hub is supported by the R Consortium and works closely with many neighboring efforts in the pharmaceutical space and broader R ecosystem.
Executive Committee
R Validation Hub is governed by an executive committee. Here is the committee, as of August 2023:
- Doug Kelkhoff (Chair)
- Joe Rickert (R Consortium)
- Preetham Palukuru (R Consortium)
- Juliane Manitz (Communications Workstream Lead)
- Coline Zeballos (Repositories Workstream Lead)
- Eric Milliman (
riskmetricWorkstream Lead) - Aaron Clark (
riskassessmentApp Workstream Lead)
Thank you to previous committee members for helping to drive the R Validation Hub forward:
Andy Nicholls (Chair 2018-2022), Lyn Taylor, Paulo Bargo, Marly Gotti, Yilong Zhang, Keaven Anderson, Min Lee, Parker Sims
Participating Organisations
The R Validation Hub comprises of participants from across the pharmaceutical industry. Participants contribute to the effort through our regular group meetings, as well as the various workstreams that make up the project.
Feel free to explore contribution opportunities and subscribe to our mailing list to stay up-to-date on our progress.
If you are a member and your organisation does not appear on this list, please let us know!
- Abbvie
- Acerta Pharma
- Amgen
- Appsilon
- Astellas
- Atorus Research
- Bayer
- BeiGene
- Biogen
- BioMarin Pharmaceutical Inc.
- Boehringer-Ingelheim
- BresMed
- Celgene
- ClinBAY
- Cognigen Corporation
- Eli Lilly
- FDA
- Galapagos NV
- Genentech
- Gilead
- GSK
- HMS Analytical Software
- IQVIA
- InModelia
- Johnson & Johnson
- Jumping Rivers
- Kite Pharma
- Linux Foundation
- Merck KGaA/EMD Serono
- MSD
- MRC-BSU
- Novartis
- Novonordisk
- Nuventra
- Parexel
- Pfizer
- Phastar
- Posit
- PPD
- ProCogia
- Quanticate
- RCPE
- Rho, Inc.
- Roche
- Sanofi
- Scharp
- Servier
- SQN Clinical
- Teva Pharmaceutical Industries Ltd.
- University of Sheffield